GNMSF vs MSFT: Which Stock is Better?
Side-by-side comparison of Genmab A/S and Microsoft Corporation in 2026
GNMSF
Genmab A/S
—
MSFT
Microsoft Corporation
$402.29
Key Metrics Comparison
| Metric | GNMSF | MSFT | Winner |
|---|---|---|---|
| Market Cap | $14.85B | $3.71T | MSFT |
| P/E Ratio | 18.39 | 38.61 | GNMSF |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GNMSF
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GNMSF or MSFT a better investment?
Comparing GNMSF and MSFT: Genmab A/S has a market cap of $14.85B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GNMSF and MSFT?
GNMSF (Genmab A/S) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GNMSF or MSFT?
Based on P/E ratios, GNMSF trades at a lower multiple (18.4x vs 38.6x).
Which is growing faster: GNMSF or MSFT?
Both GNMSF and MSFT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GNMSF or MSFT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GNMSF or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $14.85B for GNMSF.
Should I buy GNMSF or MSFT in 2026?
Both GNMSF and MSFT have investment merit. GNMSF trades at $N/A while MSFT trades at $402.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GNMSF and MSFT stock?
Key differences: Market Cap ($14.85B vs $3.71T), P/E Ratio (18.4x vs 38.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GNMSF or MSFT in 2026?
The choice between GNMSF and MSFT depends on your investment goals. MSFT shows higher revenue growth (0.0%). MSFT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GNMSF and MSFT?
GNMSF (Genmab A/S) has a market cap of $14.85B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.